In Bloomberg’s 2019 Q1 league tables, Pillsbury was recognized as the 17th most active law firm advising on middle-market mergers and acquisitions. The firm’s strong performance continues a string of positive results for Pillsbury’s M&A practice, which consistently ranked among the top legal advisers for deal making in 2018.
Some of the firm’s 2019 transactional highlights thus far include representing clinical-stage cancer treatment developer Salarius Pharmaceuticals LLC on its pending merger with Flex Pharma Inc.; advising Delta Electronics, Inc. on its $90 million acquisition of Amerlux, LLC; and guiding RhythmOne plc through its £136 million merger with Taptica International Limited.
Pillsbury is among the world’s foremost legal advisors for mergers & acquisitions of all sizes and in markets around the world. Leveraging the experience and insight of more than 100 M&A lawyers globally, the firm offers clients the strategic guidance and innovative solutions necessary to successfully close in even the most challenging transactions.